PureTech Health (Group)

https://www.puretechhealth.com

PureTech Health (PureTech Health plc, PRTC.L) is a cross-disciplinary biopharmaceutical company creating 21st century medicines that modulate the adaptive human systems. Our therapies target the immune, nervous, and gastro-intestinal systems by addressing the underlying pathophysiology of disease from a systems perspective rather than through a single receptor or pathway. We have multiple human proof-of-concept studies and pivotal or registration studies expected to read out in the next two years. PureTech Health’s rich and growing research and development pipeline has been developed in collaboration with some of the world’s leading scientific experts who, along with PureTech's experienced team and board, analyze more than 650 scientific discoveries per year to identify and advance only the opportunities we believe hold the most promise for patients. This team and process place PureTech Health on the cutting edge of ground-breaking science and technological innovation and leads the Company between and beyond existing disciplines. *

	Start	2015-06-19 existent
	Today	PureTech Health plc (LSE: PRTC)
	Person	Zohar, Daphne (PureTech Health 2016 CEO + Co-Founder)
	Person 2	Ito, Joichi (PureTech Health 2016 Chairman)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	6 St. Andrew Street
	City	EC4A 3AE London
		Address record changed: 2024-01-05

Basic data	Employees	C: 51 to 100 (2016-03-01)
	Currency	GBP
	Annual sales	11,828,000 (revenue, consolidated (2015) 2015-12-31)
	Profit	-58,244,000 (2015-12-31)
	Cash	134,751,000 (2015-12-31)

		* Document for »About Section«: PureTech Health plc. (2/24/17). "Press Release: PureTech Health to Present at the Cowen and Company 37th Annual Health Care Conference". Boston, MA.

		Record changed: 2020-11-12